Cardiovascular Bioengineering 2021 Symposium

项目摘要/摘要 这是心血管生物工程2021(CVBE 2021)研讨会的新应用 德国哥廷根大学校园。这将是研讨会召开6周年。这个 建议的CVBE研讨会的独特之处在于它结合了心血管领域的顶尖研究人员 生物工程与该领域代表不足的受训人员。实习生为研究生和博士后 心血管科学和生物医学工程方面的研究员。研讨会将为以下人士提供论坛 受训人员和初级研究人员介绍他们在基因编辑、诱导多能干细胞、 和心脏干细胞在心力衰竭的背景下，以及心血管生物工程的一般主题。这 会议是由NHLBI前体细胞生物学联盟(PCBC)发起的，并带来了 首先，PCBC心血管研究人员和他们的受训人员以及特邀演讲者一起参加了会议。2016年，作为 PCBC被NHLBI祖细胞翻译联盟(PCTC)取代，会议向公众开放 PCBC研究人员以及其他人在心血管生物工程领域广泛参与的研讨会。 多年来，会议记录和立场文件已经产生，1-5，现在公认为 干细胞和心血管生物工程的一次独特的公开和重复的科学研讨会。这个 在过去的4年里，大会增加了翻译话题以及这次会议的“面包和黄油”， 这是干细胞生物工程、分子心血管研究和 功能心肌的构建。会议的主题从组织工程学、iPS细胞、心脏 发展，在过去的两年中已经增长到包括外切体、microRNAs、线粒体、心脏基因 和心脏细胞疗法。本次会议的出席人数有所攀升，并于2019年举行了研讨会 在澳大利亚悉尼大学。来自澳大利亚、新西兰、中国、 日本、欧洲和美国。在过去的几年中，会议是在3月份举行的。会议原计划于 2020年在哥廷根大学，但由于新冠肺炎的原因，会议被取消了。幸运的是，我们能够 将会议重新安排在2021年。计划中的议程代表着一次雄心勃勃、快节奏的会议， 包括主旨讲座在内的两天多个课程。将突出年轻的心血管科学家 通过每届会议的特邀演讲。本次会议的组织者是Wolfram-Hubertus Zimmermann博士 (Göttingen)，Jay Zhang(UAB)，Timothy Kamp(UW-Madison)，Malte Tiburcy(Göttingen)，Laura Zelarayan(Göttingen)，Susanne Lutz(Göttingen)，Norman Liw(Göttingen)，Patapia Zafeiriou(Göttingen)，以及 拉比亚·辛克尔(Göttingen)。10,000美元的提案请求约占会议总数的20% 预算，正如我们在过去几年中所做的那样，这个应用程序的支持将用于 实习生旅费、少数族裔旅行奖、新的调查员旅费以及对所有会议录像的支持 这将向公众进行评估(单击此处查看2019年CVBE研讨会视频)。

PROJECT SUMMARY/ABSTRACT This is a new application for the Cardiovascular Bioengineering 2021 (CVBE 2021) Symposium to be held on the campus of the University of Göttingen, Germany. This will be the 6th Anniversary of the Symposium. The uniqueness of the proposed CVBE symposium lies in its combination of top researchers in cardiovascular bioengineering with underrepresented trainees in the field. Trainees are graduate students and post-doctoral fellows in the cardiovascular sciences and biomedical engineering. The symposium will provide a forum for trainees and junior investigators to present their work in the areas of gene editing, induced pluripotent stem cells, and cardiac stem cells in the context of heart failure as well general topics in cardiovascular bioengineering. This conference grew out of initiatives from the NHLBI progenitor cell biology consortium (PCBC) and brought together initially PCBC cardiovascular researchers and their trainees as well as invited speakers. In 2016, as the PCBC was replaced by NHLBI progenitor cell translation consortium (PCTC), the meeting grew to a public symposium to broadly engage both PCBC investigators as well as others in in cardiovascular bioengineering. Proceedings and position papers have emerged from the meeting over the years,1-5 and it is now recognized as a unique public and recurring scientific symposium of stem cell and cardiovascular bioengineering. The conference in the past 4 years has added translational topics as well as the “bread and butter” of this meeting, which is the convergences of stem cell biology bioengineering, molecular cardiovascular research, and fabrication of functional myocardium. The conference topics started with tissue engineering, iPS cells, cardiac development, and in the past 2 years has grown to include exosome, microRNAs, mitochondria, cardiac gene and cardiac cell therapy. The attendance of this conference has climbed and, in 2019, the symposium was held at the University of Sydney, Australia. There were nearly 200 attendees from Australia, New Zealand, China, Japan, Europe, and America. In past years, the conference was held in March. The conference was planned for 2020 at the University of Göttingen, but the meeting was cancelled due to COVID-19. Fortunately, we are able to reschedule the meeting for 2021. The planned agenda represents an ambitious, fast-paced meeting with multiple sessions over 2 days including the Keynote lecture. Young cardiovascular scientists will be highlighted through invited talks at each session. Organizers of this meeting are Drs. Wolfram-Hubertus Zimmermann (Göttingen), Jianyi (Jay) Zhang (UAB), Timothy Kamp (UW-Madison), Malte Tiburcy (Göttingen), Laura Zelarayan (Göttingen), Susanne Lutz (Göttingen), Norman Liaw (Göttingen), Patapia Zafeiriou (Göttingen), and Rabea Hinkel (Göttingen). The proposal request of $10,000 constitutes approximately 20% of the total meeting budget, and as we have done over the last several years, support from this application will be used towards the cost of trainee travel, minority travel awards, new investigator travel, and support for videotaping all sessions that will be assessable to the public (Click here to view 2019 CVBE Symposium videos).